Enochian Biosciences is a pre-clinical stage biotech that purchased its HIV drug IP from Weird Science, LLC. ENOB's lead scientist and HIV IP inventor does not appear to have any biotech experience, ...
LOS ANGELES, May 25, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB). The Board of Directors of Enochian BioSciences Inc. met today and expressed unanimous and strong affirmation of the current position of ...
LOS ANGELES, Nov. 25, 2019 (GLOBE NEWSWIRE) -- Enochian Biosciences, a company focused on gene-modified cellular therapy in infectious disease and cancer, announces the expansion of its infectious ...
Enochian Biosciences Inc (NASDAQ:ENOB) shares are trading lower Wednesday after Hindenburg Research issued a bearish report on the company. Hindenburg noted that Gumrukcu is not only the co-founder of ...
It's not every day that a biotech's scientific co-founder is arrested on murder-for-hire charges. But the aftermath of that arrest is just what Enochian Biosciences' CEO faces now—and he's fighting ...
If convicted of the federal grand jury charges against them, Gumrukcu and Eratay face mandatory life in prison or the death penalty. Shares of the company’s stock plummeted 38.8% on the news. 3 Summer ...
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Enochian BioSciences Inc. (NASDAQ: ENOB) shares more than ...
Electronic trading platform E-Trade has reportedly blocked customers from buying Enochian Biosciences stock after the biotech announced the Food and Drug Administration had accepted its Pre-IND ...
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Enochian ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback